As UT Southwesterns Chief and Professor of Obstetrics and Gynecology, Catherine Spong, M.D., noted in Vox, that excluding pregnant patients from GLP-1 RA research over safety concerns is to provide care without adequate evidence. A 2023 observational study involving 50,000 pregnant women with Type 2 diabetes found no statistically significant differences in the number of major congenital malformations among the more than 900 women who were taking GLP-1 RAs when they learned they were pregnant
Potential side effects to GLP-1 agonists: understanding their safety and tolerability
RAPID-ACTING FORMULA Platinum 100% L-Carnitine 1500 is a delicious liquid carnitine formula that features a mega-dose of 1,500mg of L-carnitine in each serving
Semaglutide, a weight loss drug recently approved by the FDA and sold under the name Wegovy, is now available
As the market continues to evolve, stakeholders must remain vigilant to emerging trends and shifts in consumer preferences, which could significantly influence strategic decisions moving forward